GlycoNet scientists are expanding our knowledge of sugars to engineer new health solutions.
Over 150 top researchers, industry experts, and emerging talent in glycomics recently gathered in Edmonton, Alberta to discuss advancements and the latest trends in glycomics.
GlycoNet and its Integrated Services advance glycomics research and innovation towards new solutions.
Five glycomics projects have been awarded funding to develop new tools, diagnostics and therapeutics to improve health for Canadians.
A significant gathering of researchers, industry experts, and rising stars in glycomics recently took place in Edmonton, Alberta with the Honourable Randy Boissonnault, focusing on advancements and current trends in the field.
Finding that the skin of people with scleroderma makes a unique sugar, GlycoNet researcher Lisa Willis is developing a way to better identify those at high risk of disease progression.
PlantForm Corporation has teamed up with a University of British Columbia research group led by Dr. Joerg Bohlmann to develop a novel plant-based treatment option for Type-2 diabetes and obesity, with support from GlycoNet.
By remodelling sugars on cell surfaces, GlycoNet researchers aim to map the linkages between proteins in the immune system and sugars on cancer cells
Applying a glycomics lens to the problem of organ donor-recipient compatibility, GlycoNet researcher Dr. Lori West is advancing the field of organ transplantation.
It’s all about monitoring sugar – but not in the way you may think